Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to patents for its narcolepsy drug, Sunosi (solriamfetol). The settlement ...

A direct English translation of the Arabic word 'ilm علم is "knowledge", but the Arabic appellation is pregnant with meanings that transcend what knowledge implied for the likes of Plato, Pythagoras, ...

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...

Amman, Jordan: Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024. The Group reported revenue growth of 9% (9% ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

The margin also softened, to 22.8% from 24.6% in 2023. As at 0830 GMT, shares in Hikma were down 8% at 2,122p. Riad Mishlawi, chief executive, insisted it had been "another strong year" for the ...

Hikma Pharmaceuticals reported a strong financial performance for 2024, with revenue rising nine per cent to $3.13bn (£2.47bn) and operating profit up 67 per cent to $612m (£483m). Profit ...

Group core revenue up 10%, including contribution from Xellia acquisition (9% organic). Reported Group revenue up 9% Core revenue up in all three business segments – Injectables up 10%, Branded up 8% ...

As if things didn’t already feel dystopian enough: This morning, Bhad Bhabie — née Danielle Bregoli, of “Cash Me Outside” fame — dropped a diss track aimed at Alabama Barker ...

Ahmed al-Shara’s unlikely path from membership in Al Qaeda to head of state has raised questions about how he intends to govern Syria. Ahmed al-Shara’s unlikely path from membership in Al ...